Monthly Archives: July 2018

Post navigation

Because cancer-related genes associated with cellular proliferation steadily increased, those associated with cell-cycle checkpoint control and cell-type specification were down-regulated. This indicates that patients with progressive liver disease experience a loss of differentiation and checkpoint cell-cycle arrest, consistent with the concordant gradual increase in proliferative capacity. This also suggests a mechanism by which chronic HCV infection contributes to tumorigenesis of hepatocellular

carcinoma (HCC). The SVD-MDS method used in the analysis presented in Fig. 2G-J and Supporting Fig. 1G-J allows the computation of two additional parameters aside from Kruskal stress (i.e., information loss during dimensionality reduction): external isolation (i.e., the arithmetic average intergroup selleck chemicals distance) AZD1208 and internal cohesiveness (i.e., the intragroup distance). Both parameters determined for the analyses peak 3-6 months post-OLT (Fig. 4A), indicating that the signatures derived from these time categories generate the relative maximal resolution. Hence, the early stages

of HCV reinfection best characterize overall clinical outcome. We then used the time-specific analysis to define a gene-expression pattern-based distance measure between any of the individual groups and with combined G2345 and G345, as well as G45 longitudinal analysis. To investigate severe liver disease progression according to time and patient outcome, these measures were then subjected to k-means clustering13 using intergroup distances as additional constraints. This analysis indicates the existence of a common precursor

state (G345) for all progressor groups (Fig. 4B, red), from which all three adverse outcomes split individually. This precursor state is comprised of 35 DEGs (Table 2), which distinguish the transformation to a progressive disease outcome long before histological or clinical evidence of severe disease. In the 上海皓元医药股份有限公司 absence of time-resolved samples from healthy, non-HCV patients, we were not able to determine whether a common G2345 (Fig. 4B, black) state exists or how this hypothetical intermediate state would relate to G2 and G345. More important, the predicted common G345 precursor state confirmed our observation that eventual severe liver disease is programmed early post-OLT, and in combination with the time-specific analyses described above, identified DEGs distinguishing progressors and nonprogressors within 6 months of transplantation. Using IPA, we generated a network of directly interacting molecules based on the network analysis of the transitional signature and the G345e time-specific gene sets (Fig. 4C and Supporting Fig. 2). We confirmed that repression of genes involved in cell-cycle regulation and stress responses (e.g., cyclin D1 and X-box-binding protein), innate immunity (e.g.

Because cancer-related genes associated with cellular proliferation steadily increased, those associated with cell-cycle checkpoint control and cell-type specification were down-regulated. This indicates that patients with progressive liver disease experience a loss of differentiation and checkpoint cell-cycle arrest, consistent with the concordant gradual increase in proliferative capacity. This also suggests a mechanism by which chronic HCV infection contributes to tumorigenesis of hepatocellular

carcinoma (HCC). The SVD-MDS method used in the analysis presented in Fig. 2G-J and Supporting Fig. 1G-J allows the computation of two additional parameters aside from Kruskal stress (i.e., information loss during dimensionality reduction): external isolation (i.e., the arithmetic average intergroup Doramapimod price distance) BYL719 supplier and internal cohesiveness (i.e., the intragroup distance). Both parameters determined for the analyses peak 3-6 months post-OLT (Fig. 4A), indicating that the signatures derived from these time categories generate the relative maximal resolution. Hence, the early stages

of HCV reinfection best characterize overall clinical outcome. We then used the time-specific analysis to define a gene-expression pattern-based distance measure between any of the individual groups and with combined G2345 and G345, as well as G45 longitudinal analysis. To investigate severe liver disease progression according to time and patient outcome, these measures were then subjected to k-means clustering13 using intergroup distances as additional constraints. This analysis indicates the existence of a common precursor

state (G345) for all progressor groups (Fig. 4B, red), from which all three adverse outcomes split individually. This precursor state is comprised of 35 DEGs (Table 2), which distinguish the transformation to a progressive disease outcome long before histological or clinical evidence of severe disease. In the MCE absence of time-resolved samples from healthy, non-HCV patients, we were not able to determine whether a common G2345 (Fig. 4B, black) state exists or how this hypothetical intermediate state would relate to G2 and G345. More important, the predicted common G345 precursor state confirmed our observation that eventual severe liver disease is programmed early post-OLT, and in combination with the time-specific analyses described above, identified DEGs distinguishing progressors and nonprogressors within 6 months of transplantation. Using IPA, we generated a network of directly interacting molecules based on the network analysis of the transitional signature and the G345e time-specific gene sets (Fig. 4C and Supporting Fig. 2). We confirmed that repression of genes involved in cell-cycle regulation and stress responses (e.g., cyclin D1 and X-box-binding protein), innate immunity (e.g.

6 Xingshun Qi*, Guohong AZD9668 mouse Han*, Daiming Fan*, * Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi’an, China. ““We congratulate the investigators for their comprehensive review on cancer surveillance in patients with primary sclerosing cholangitis (PSC).1 Annual ultrasound (US) examinations have been proposed by the American2 as well as European practice guidelines,3 and cholecystectomy is recommended for gallbladder (GB)

polyps detected independent of their size. In their current review, Razumilava et al. discuss an alternative strategy consisting of repeat imaging every 3-6 months for the surveillance of polyps of less than 8 mm in size.1 This strategy is

based on reports that most GB cancers detected in patients with PSC arise in polyps well above this size.4, 5 We here report on 2 of our patients with GB polyps detected by regular imaging surveillance within the last year. The first patient is a 38-year-old male with a 10-year history of PSC. A 6-mm GB polyp was detected on surveillance US. The patient was advised to have a follow up US within 3-4 months and actually presented 6 months later. The polyp Ibrutinib in vivo had grown to a size of 4 × 2 cm. Surgery revealed an advanced GB adenocarcinoma with multiple small bilobar liver metastases. 上海皓元 The second patient is a 44-year-old male with a 6-year history of PSC. He presented with a 1.6-cm GB polyp 8 months after having received magnetic resonance imaging of his liver without any pathology of the GB. Cholecystectomy revealed a tubular adenoma with focal high-grade dysplasia. These 2 cases underline that GB polyps may grow rapidly in patients with PSC. The first patient might have been cured if immediate cholecystectomy had been performed, as recommended

by our current guidelines. The second patient might have developed GB cancer if a longer surveillance interval had been chosen. Yearly surveillance examinations, as recommended by the current guidelines, may not be appropriate in this high-risk population. We now recommend for our patients surveillance intervals of 6 months. More important, we should be cautious not to delay cholecystectomy in a patient with PSC and a GB polyp independent of its size, unless surgical risk far outweighs the benefit of potentially preventing a deadly cancer. Christoph Schramm M.D.*, Ansgar W. Lohse M.D.*, * Department of Medicine I, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. ““We read with great interest the article entitled “Autoimmune Acute Liver Failure: Proposed Clinical and Histological Criteria” by Stravitz et al.1 Our reading of this article has given rise to several comments.

provide survival benefit to non-responder to HAIC. ““Background and Aim: Platelets provide many functions in the body, especially to the liver. The purpose of this study is to investigate the effect of thrombocytosis with acute hepatitis induced by anti-Fas antibody and its mechanism. Methods: Acute hepatitis was induced by administration of anti-Fas antibody in normal and thrombocytotic C57BL6J mice. For thrombocytosis, thrombopoietin; PEG-rHuMGDF was injected 5 days before and just prior to administration of anti-Fas MI-503 antibody. To investigate the mechanisms, hepatocyte cell line (AML12) and sinusoidal endothelial cell line (M1) were induced apoptosis by staurosporine. They were cultured with platelets or thrombopoietin. Examination items were as follows: platelet number, alanine aminotransferase (ALT), histological findings, TUNEL (TdT-mediated dUTP-biotin Nick

End Labeling) staining, and the expression of proteins associated with apoptosis in vivo and in vitro. Results: Platelets were significantly increased in the thrombocytotic group (P 上海皓元 in the thrombocytotic

group. The phosphorylation of Akt, the increment of Bcl-xL and the decrease of cleaved caspase-3 were observed in AML12 cells cultured with platelets, but were not observed cultured with thrombopoietin. Platelets and thrombopoietin had no anti-apoptotic effect on M1 cells. Conclusion: Increase of platelets has a preventative effect against acute hepatitis induced by the anti-Fas antibody. It is suggested that platelets have a direct protective effect against apoptosis of hepatocytes. ““Goel GA, Deshpande A, Lopez R, Hall GS, van Duin D, Carey WD. Increased rate of spontaneous bacterial peritonitis among cirrhotic patients receiving pharmacologic acid suppression. Clin Gastroenterol Hepatol 2012;10:422-427. (Reprinted with permission.) BACKGROUND & AIMS: Patients with cirrhosis frequently receive proton pump inhibitor (PPI) or H2-receptor antagonist therapies. We investigated whether acid-suppressive therapy is associated with spontaneous bacterial peritonitis (SBP) in cirrhotic patients with ascites.

Therefore, the hepatic uptake of αMCA and DCA might be an important determining factor in the excretion of these BAs, especially for DCA, which originates from the bacterial activity in the intestine. Studies in rats indicate that rodent liver has high capacity of conversion of CDCA to βMCA, but not to αMCA.25, 26 Thus, the selective decrease of biliary excretion of αMCA, but not βMCA, is likely due to their differences in Selleck C59 wnt hepatic synthesis in Oatp1b2-null mice. For further characterization of the in vivo role of Oatp1b2 in BA transport, WT and Oatp1b2-null mice were injected with CA or T-CA (Fig. 4). The plasma concentration

of CA is approximately 3 fold higher in Oatp1b2-null mice after the intravenous administration of CA (Fig. 4). In CA-injected mice, the Vd of the central compartment

is approximately 50% smaller in Oatp1b2-null than in WT mice. The smaller Vdcentral results in a 55% lower hepatic clearance in Oatp1b2-null mice (Fig. 5). In contrast to CA, T-CA concentrations are similar in Oatp1b2-null and WT mice after intravenous administration of T-CA. This finding confirmed the key role of Oatp1b2 in the hepatic uptake of unconjugated BAs. It can be assumed that the reabsorption of BAs by the ileum is not altered in the Oatp1b2-null mice, because there are no changes in either the BA levels in small intestine content (Supporting Information Fig. http://www.selleckchem.com/products/Adrucil(Fluorouracil).html 3) or in the mRNA/protein expression of the BA transporters in the ileum (Asbt and Ostα/β, data not shown) in Oatp1b2-null mice compared with WT mice. Therefore, application of a pharmacokinetic equation after intravenous infusion ( ) is consistent with the constant high concentrations of unconjugated BAs in Oatp1b2-null mice, where Css is the steady-state concentration, DR is the dose rate (in MCE公司 this case

the intestinal absorption of BAs), and Cl is clearance. In Oatp1b2-null mice, the Css is higher than in WT mice, because of the decreased hepatic clearance of unconjugated BAs. The homeostasis of hepatic BAs is regulated not only by transporters but also by the de novo biosynthesis of BAs from cholesterol. Because the disposition of unconjugated BAs is altered in Oatp1b2-null mice, the gene expression of BA synthetic enzymes was examined. Surprisingly, the mRNA expression of Cyp7a1, the rate-limiting enzyme of BA synthesis,27 is 70% lower in Oatp1b2-null mice (Fig. 7). The absence of Oatp1b2 does not influence other key enzymes either in the classical or in the alternative BA synthetic pathway (Fig. 7). The regulation of Cyp7a1 is complex. Cyp7a1 is a target gene of liver X receptor α (LXRα) in rodents.28 A high cholesterol diet increases bile acid synthesis in WT but not in LXRα-null mice, which results in high levels of cholesterol in livers of LXRα-null mice.29 Serum total cholesterol is higher in Oatp1b2-null than in WT mice.

Response repetitions occurred on repeat trials only with equal frequency across both tasks. The data were analysed with these trials included Target Selective Inhibitor Library and also excluded. Subjects switched between letter and digit naming on every second trial, as in the Rogers et al. (1998) procedure. In the letter naming task, subjects were required to name the letter

as fast and as accurately as possible. In the digit naming task, subjects were required to name the digit as fast and as accurately as possible. Subjects had to select the currently appropriate character and simply vocalize it, rather than apply a new response rule to it as in the abstract rule condition. Responses

were recorded using a voice key and as in the Rogers et al. (1998) design, there were no stimulus, and hence, no response repetitions. The task started with a training session in which subjects practised switching between categorizing letters as vowels and consonants, and numbers as higher or lower than 5, and naming numbers and letters. This session comprised two 24-trial blocks, one for each rule condition. In the experiment proper, the two rule conditions, each comprising eight blocks of 40 trials, were administered in two sessions with a short intervening rest break. Each session comprised half the blocks of each experimental Dinaciclib clinical trial condition, and the sequence of the rule blocks within a session was counterbalanced within groups. Between blocks, the word ‘Ready’ was displayed on the screen until the experimenter pressed the space-bar for the next block to begin. A Paceblade SlimBook P120 Centrino 12.1 XGA Panel Wide Angle View was used as a testing machine and the task was programmed in Visual Basic and run using the Whisker control system (Cardinal & Aitken, 2001) to ensure that

responses were measured to millisecond accuracy. A purpose-built voice key was used to record reaction times. Errors and voice key trigger failures were monitored and manually coded on a scoring sheet by the experimenter during testing and subsequently removed from the datasets. The first two trials of a block and 上海皓元 trials deemed unreliable due to voice key errors or irrelevant vocalizations were excluded from the analyses. Reaction time (RT) on trials where an error had occurred as well as the following trial, and RTs shorter than 300 ms were also excluded. RTs were subjected to means trimming to exclude all datapoints beyond 2.5 SD from each condition mean for each individual. Error rates were arcsin-transformed, as the variance was proportional to the mean (Howell, 1997). The raw RT and error rates are presented in Table 4.

Response repetitions occurred on repeat trials only with equal frequency across both tasks. The data were analysed with these trials included this website and also excluded. Subjects switched between letter and digit naming on every second trial, as in the Rogers et al. (1998) procedure. In the letter naming task, subjects were required to name the letter

as fast and as accurately as possible. In the digit naming task, subjects were required to name the digit as fast and as accurately as possible. Subjects had to select the currently appropriate character and simply vocalize it, rather than apply a new response rule to it as in the abstract rule condition. Responses

were recorded using a voice key and as in the Rogers et al. (1998) design, there were no stimulus, and hence, no response repetitions. The task started with a training session in which subjects practised switching between categorizing letters as vowels and consonants, and numbers as higher or lower than 5, and naming numbers and letters. This session comprised two 24-trial blocks, one for each rule condition. In the experiment proper, the two rule conditions, each comprising eight blocks of 40 trials, were administered in two sessions with a short intervening rest break. Each session comprised half the blocks of each experimental ICG-001 price condition, and the sequence of the rule blocks within a session was counterbalanced within groups. Between blocks, the word ‘Ready’ was displayed on the screen until the experimenter pressed the space-bar for the next block to begin. A Paceblade SlimBook P120 Centrino 12.1 XGA Panel Wide Angle View was used as a testing machine and the task was programmed in Visual Basic and run using the Whisker control system (Cardinal & Aitken, 2001) to ensure that

responses were measured to millisecond accuracy. A purpose-built voice key was used to record reaction times. Errors and voice key trigger failures were monitored and manually coded on a scoring sheet by the experimenter during testing and subsequently removed from the datasets. The first two trials of a block and medchemexpress trials deemed unreliable due to voice key errors or irrelevant vocalizations were excluded from the analyses. Reaction time (RT) on trials where an error had occurred as well as the following trial, and RTs shorter than 300 ms were also excluded. RTs were subjected to means trimming to exclude all datapoints beyond 2.5 SD from each condition mean for each individual. Error rates were arcsin-transformed, as the variance was proportional to the mean (Howell, 1997). The raw RT and error rates are presented in Table 4.

Excess serum or hepatic iron PF-02341066 price is a relatively frequent finding in HCV-infected patients, and has been associated with poor response to treatment, greater disease severity, and an increased risk of hepatocellular carcinoma.31, 34-38 Despite the presence of chronic inflammation, hepcidin levels in HCV patients are relatively reduced, thus preventing the appropriate regulation of iron absorption and release, leading to systemic

and hepatic iron excess.39, 40 In vitro studies have suggested that iron may enhance HCV replication,41, 42 although this has recently been challenged.43 Moreover, several reports have suggested an improved disease course and augmented treatment response following iron reduction therapy.31,

32 Weekly PEG-IFN-α administration, with hepcidin induction and the subsequent iron redistribution, may be of similar benefit to HCV patients. Indeed, reduced hepatic iron and an amelioration of hepcidin suppression have been reported following successful HCV eradication.44-46 Novel data from this study extends these clinical observations. Conversely, chronic hepcidin induction may contribute to the anemia associated with PEG-IFN-α therapy, through the development of iron-restricted erythropoiesis.47 IFN-α treatment exerts its antiviral effect through the induction of interferon-stimulated genes (ISGs) by way of activation of the Jak/STAT pathway.4, 5 Although ISG induction is predominantly by PS-341 in vitro way of the STAT1 and STAT2 transcription factors, STAT3 activation, which mediates the inflammatory induction of hepcidin, is also critical to the antiviral effect

of IFN-α.48, 49 The significant correlation seen between serum hepcidin and CRP levels in HCV patients likely reflects STAT3 activation following PEG-IFN-α initiation.28, 50 Interestingly, disruption of STAT signaling by way of the suppressor of cytokine signaling-3 (SOCS3) has been reported in nonresponders to treatment in HCV, whereas this molecule also inhibits the induction of hepcidin by inflammation, and potentially its downstream effects on iron regulation.23, 51 This interference may be reflected in the differences in the MCE ability of hepcidin to regulate iron levels between treatment responders and nonresponders seen here (Fig. 3D,E). In summary, hepcidin, the master regulator of iron homeostasis, is identified here as an IFN-α-responsive gene. IFN-α induces hepcidin production by way of the Jak/STAT3 signaling pathway, with increased serum hepcidin seen in HCV patients following a single PEG-IFN-α dose. The consequent systemic iron withdrawal was greatest in those with the most marked viral response to PEG-IFN-α, implicating hypoferremia as a surrogate marker of immediate PEG-IFN-α efficacy. The authors thank Dr. Jennifer Russell, Dr. Flavia D’Alessio, and Dr. Katarzyna Mleczko-Sanecka for excellent technical assistance and advice, and Dr.

The area of lower body of stomach provides the greatest interface between the stomach and the anterior abdominal wall.[20] It provides the shortest, most direct passage into the stomach. The lower position within the Autophagy Compound Library ic50 stomach places the PEG near the antrum, which facilitates conversion of the PEG to a percutaneous endoscopic gastrojejunostomy. Percutaneous endoscopic gastrojejunostomy

is the method of choice if patient had delayed gastric emptying associated with PEG feeding intolerance.[21] After insufflation with 500 mL of air, we used the abdominal plain film before PEG in 84 patients. PEG was unsuccessful in one (1.2%) patient because the stomach was positioned high behind the ribs. One patient developed an acute abdomen and required explorative laparostomy 7 days after the procedure.[9] An underinflated stomach may fail to displace the colon, or paradoxically, overinflation may lead to gas entering and distending Selleck XL765 the small bowel, hence lifting the colon upward.[9] Insufflation of the stomach with air has been routinely practiced in patients suspected of having perforated peptic ulcer or to verify the correct PEG tube replacement.[22, 23] Using 300–400 mL of air along with plain film radiography is sufficient to outline most adult stomachs.[22-24] After reviewing the results

of studies, we have increased the amount of air injected to 500 mL because this will make it more likely to obtain a fully distended stomach on the abdominal plain film.[9] During the traditional Ponsky “pull” technique, 500 mL of air is administered through a nasogastric tube or endoscope to obtain adequate distention of the stomach. Large amounts of air in the stomach may leak through the pyloric sphincter

into the small intestine. Theoretically, a longer PEG procedure time may led to more air volume passing into the small intestines, decrease the tension and volume in the air-distended stomach, increase the amount of air in the proximal 上海皓元医药股份有限公司 small intestine, lift the colon upward, and cause additional risk of complications. An abdominal plain film with 500 mL air insufflation was performed 1 day before the PEG tube placement. A nasogastric tube was used to decompress the stomach filled with excessive air. After an overnight fasting just before PEG, the patient was placed on supine position, and 500 mL of air was administered through a nasogastric tube into the stomach.[9] Abdominal plain film with air insufflations was obtained the day before PEG. The position and volume of colon gas are changeable, and the appropriate site of PEG might differ from day to day. For patients with potentially bowel loop lying in front of the stomach, safe track technique and fine guiding needle to locate an appropriate puncture track are used (Fig. 1). The part of the liver that is in front of the stomach occasionally cannot be seen in the abdominal plain film.

Although this is a conservative approach, such restriction was necessary to maximize the study’s accuracy. Because the liver is a frequent site for metastatic disease, all patients with prior cancer diagnoses in the 5 years preceding the tumor diagnosis were excluded. Finally, the identification of preceding

medical conditions using Medicare claims records rather than personal interview data likely avoided recall bias. In summary, the results of this population-based study indicate that metabolic syndrome is a significant risk factor for development of both types of primary liver cancer, regardless of the presence of all other major HCC and ICC risk factors. As a result, metabolic syndrome may explain a relevant proportion of idiopathic HCC or ICC in the United States. Consequently, approaches to control the recent

worldwide epidemic of metabolic CHIR-99021 chemical structure syndrome could contribute to a reduction in the liver cancer burden. ““Osteopontin (OPN) is a multifunctional protein, involved in pathological conditions including inflammation, immunity, angiogenesis, fibrosis and cancer progression in various tissues. Hepatic inflammation and fibrosis induced by feeding with a diet deficient in methionine and choline (MCD diet) were markedly attenuated in OPN knockout mice when compared with wild-type mice in the model of non-alcoholic Alisertib solubility dmso steatohepatitis (NASH). Hepatic cholangiocytes, myofibroblastic stellate cells and natural killer T cells MCE公司 were suggested to secret OPN in mice fed an MCD diet. Plasma and hepatic OPN levels were significantly higher in patients with NASH with advanced fibrosis than in those with early fibrosis. Hepatic OPN mRNA level was correlated with hepatic neutrophil infiltration and fibrosis in patients with alcoholic liver diseases. In those with hepatocellular carcinoma (HCC), OPN levels in plasma and HCC were prognostic factors after liver resection or transplantation. Downregulation of OPN inhibited tumor growth and lung metastasis in nude mice implanted with HCC cells. The single nucleotide polymorphism in the promoter region of the OPN gene was shown to be associated with activity

of hepatitis in chronic hepatitis C patients, prognosis in patients with HCC, and growth and lung metastasis of HCC xenografts in nude mice. OPN was reported to be a downstream effecter of Hedgehog pathway, which modulates hepatic fibrosis and carcinogenesis. This review focuses on the roles of OPN in hepatic inflammation, fibrosis and cancer progression. Further elucidation of cellular interactions and molecular mechanisms associated with OPN actions may contribute to development of novel strategies for treatment of the liver diseases. OSTEOPONTIN (OPN) WAS first described as a phosphoprotein secreted by a transformed cell line in 1979.[1] Several years later, the bone-specific sialoprotein was cloned as a matrix protein and termed “osteopontin”.